Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Novartis fails latest bid to block Entresto copies
Americas
Judge said it was unjustified to allow pharma giant’s exclusivity to continue indefinitely | Loss of monopoly over $7.8bn drug set to have marked revenue impact on the company.   22 July 2025
BMS blocks biosimilar version of blockbuster cancer drug in India
Americas
Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | BMS’s Indian patent covering the monoclonal antibody expires in May 2026.   21 July 2025
AbbVie blocks Humira antitrust suit
Europe
Non-profit alleges that Humira pricing displaced essential healthcare, violated EU competition law and breached human rights | Court notes ‘social significance’ of case—but this can’t translate into ‘legal standing’.   18 July 2025
Europe
Pharma giant can’t stop generics from unveiling copies of flagship product | Lord Justice Arnold upholds UK findings of lack of inventive step and insufficiency.   17 July 2025
Careers
Three of the new shareholders have IP and life sciences expertise, bringing a commercial and policy focus to the firm.   17 July 2025
Americas
Pharma giant wins preliminary injunction ‘in public interest’ regarding a generic of its Selenious Acid Injection | Judge finds infringement by pharma company Eugia of two Orange Book patents.   16 July 2025
Europe
After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking to Sarah Speight, the pair explain what makes a good IP strategy, why the UPC is largely “useless” without SPCs, and more.   15 July 2025
Americas
Janssen filed patent infringement suits in New Jersey and Delaware over proposed copy of blockbuster drug Invega Sustenna | Lawsuits follow appeals court win for J&J in separate action with Teva and Mylan.   15 July 2025
Americas
This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of increased transparency requirements in clinical trials and their effects on the global patent system. The session focuses on recent regulatory changes, especially in Europe, and the challenges they present for IP protection.   14 July 2025
Careers
New hire is deeply involved in the litigation space and has co-founded two software businesses.   11 July 2025